Medical Care
Tempus & Northwestern Medicine Team Up for AI in Healthcare
2024-11-26
Chicago, a city at the forefront of medical innovation, witnessed a significant event on October 31, 2024. Tempus, a renowned leader in artificial intelligence and precision medicine, joined forces with Northwestern Medicine, Chicago's premier integrated academic health system. This collaboration holds the promise of transforming healthcare through the application of AI in clinical care and research.

Uniting AI and Healthcare for Better Patient Outcomes

Exploring the Application of AI in Clinical Care

In the complex landscape of healthcare, this partnership between Tempus and Northwestern Medicine stands as a beacon of hope. By leveraging the power of data-driven insights, they aim to revolutionize patient care. Eric Lefkofsky, CEO and Founder of Tempus, emphasizes the significance of this alliance, stating, "As we navigate the intricate web of healthcare, this collaboration underscores our commitment to using AI-enabled methods to transform patient care. We are not merely treating diseases; we are uncovering pathways to better outcomes, faster diagnoses, and more personalized treatment plans."Northwestern Medicine is taking a significant step forward by deploying Tempus' technology across its care teams in cardiology. This initiative allows them to identify patients at an increased risk of developing atrial fibrillation (AFib) or any of the seven structural heart diseases (SHD). These diseases include those affecting the mitral, aortic, and tricuspid valves, abnormal heart function, and abnormal heart thickening. Northwestern Medicine becomes the first provider to clinically deploy Tempus' ECG-AF algorithm, an FDA-cleared device that utilizes AI to assist physicians in identifying patients at a higher risk of atrial fibrillation/flutter (AF). This algorithm is designed to analyze recordings from 12-lead electrocardiogram (ECG) devices and detect signs associated with a patient experiencing AF within the next 12 months. By doing so, these patients can be efficiently referred to a clinician for further diagnostic evaluation. As part of this initial rollout, both organizations will collaborate on a clinical research trial that will leverage a variety of Tempus technologies using ECG data.

The Impact on Patient Care at Northwestern Medicine

Northwestern Medicine is deeply committed to applying innovative technologies to enhance patient care. As Howard Chrisman, MD, president and chief executive officer of Northwestern Memorial HealthCare, highlights, "Artificial intelligence has the potential to be a game-changer in healthcare. It will take a collaborative effort from all stakeholders to unlock its true potential and ensure its safe and ethical deployment in research and patient care settings." With its 11 hospitals and over 200 diagnostic and ambulatory sites, Northwestern Medicine offers patients access to world-class, compassionate care. For 13 consecutive years, Northwestern Memorial has been recognized on the Best Hospital Honor Roll by U.S. News and World Report, with 11 specialties ranking nationally. Notably, Northwestern Memorial is one of only three hospitals in the nation to receive a U.S. News rating of High Performing in all procedures and conditions. This commitment to excellence positions Northwestern Medicine as a leader in integrating AI into healthcare.
New York State's González-Rojas Bill Ensures Kids' 6-Year Healthcare
2024-11-26
Children in New York State are now set to enjoy continuous healthcare coverage from birth until the age of six. This significant development comes after a bill introduced by Queens Assembly Member Jessica González-Rojas and State Sen. Samra Brouk of Rochester was passed in the state budget. The bill, A8146/S7747, which was introduced in October 2023, aimed to simplify enrollment in Child Health Plus and Medicaid, ensuring that the youngest New Yorkers have uninterrupted access to healthcare.

Expanding Healthcare Access for New York's Youngest

Benefits of Continuous Healthcare Coverage

Providing continuous coverage for children aged six and under leads to a multitude of benefits. A Georgetown University study found that it results in better health, reduced school absenteeism, and improved academic performance. Extended coverage for children can potentially lead to fewer lost work days for parents and reduced medical debt. Even a short gap in coverage can result in a child missing needed care for chronic conditions like asthma, which can lead to emergency room visits and missed school days.

New York is now one of seven states to offer this continuous coverage, and more than 800,000 children under the age of six are enrolled in Medicaid or Child Health Plus and could benefit. This change will mean less absences in childcare or school for our little ones and fewer missed days at work for parents, as stated by González-Rojas. Brouk, on the other hand, said the bill "lifts the burden of annual re-enrollment" by offering continuous healthcare coverage to children aged six or under. This legislation will support parents by giving children access to preventative care without interruptions, reducing barriers in healthcare and ensuring that our young people receive the care they deserve.

Support for the Legislation

New York Legal Assistance Group (NYLAG), Community Service Society (CSS), the Schuyler Center for Analysis and Advocacy, Medicaid Matters NY, the NYC Health and Hospitals System, the Robin Hood Foundation, SEIU 1199, and SEIU Doctors Council all supported the legislation when it was introduced last year. Kate Breslin, president and CEO at the Schuyler Center for Analysis and Advocacy, stated that uninterrupted healthcare coverage can provide several benefits for children and their families. Parents can access regular check-ups, scheduled vaccines, and preventive health services for their child, setting them up for a healthy start. Continuous Medicaid and CHP coverage is a big win for children and families across the state and ensures that New York will remain a leader in providing affordable, comprehensive health insurance coverage for children.

See More
Arlington Capital Buys TEAM Technologies for Healthcare Portfolio
2024-11-26
Arlington Capital has made a significant move in the healthcare sector by acquiring TEAM Technologies. This acquisition is set to strengthen their healthcare portfolio and enhance supply chain capabilities. Let's delve deeper into the details.

Arlington Capital's Strategic Healthcare Acquisition

Acquisition Details

Private equity firm Arlington Capital has recently sealed a deal to acquire US-based medical device manufacturer TEAM Technologies from Clearlake Capital. TEAM Tech specializes in manufacturing and supply chain solutions, offering end-to-end outsourced design and manufacturing services to medical device and pharmaceutical OEMs. It has been focusing on advanced medical devices crucial for healthcare systems.Arlington Capital managing partner Matt Altman emphasized that TEAM Tech is dedicated to providing holistic solutions for healthcare OEMs' design and manufacturing needs while strengthening supply chains to ensure the timely delivery of critical goods.Arlington principal Gordon Auduong expressed excitement about working with TEAM Tech's management team and building on its foundation through organic investment and strategic acquisitions.TEAM Tech CEO Marshall White, with 25 years of experience, believes Arlington is the ideal partner to accelerate the company's growth and take it to the next level.

Arlington's Fund and Previous Investments

Arlington is currently investing from its $3.8bn VI Fund and has made investments in over 175 companies across healthcare, aerospace, and business service sectors since 1999. Recent healthcare investments include Afton Scientific, Riverpoint Medical, and Grand River Aseptic Manufacturing.

Other Healthcare PE Deals This Month

In addition to the TEAM Technologies acquisition, other healthcare PE deals have been making waves. Charme Capital Partners acquired Germany-headquartered biotech Centogene for around $9m, and Nexxus Iberia's PE Fund II secured a majority stake in Spanish diagnostic imaging company Vivo Diagnostico.Arlington enlisted Harris Williams as financial advisor and Goodwin Procter LLP as the legal adviser during the buy-up process of TEAM Tech.Access the most comprehensive Company Profiles on the market powered by GlobalData. Save hours of research and gain a competitive edge. You can view profiles in store and request a free sample by submitting the form. We are confident in the unique quality of our Company Profiles and want you to make the best decision for your business.Sign up for our daily news round-up to give your business an edge with our leading industry insights.
See More